Author

T. R. OMeara

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

A. Chang· 1 shared A. G. Schmidt· 1 shared A. Hodgins-Davis· 1 shared A. M. Weber· 1 shared A. Ozonoff· 1 shared A. Z. Xu· 1 shared B. M. Hauser· 1 shared C. Dillen· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Chang

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Human commensal Candida albicans strains demonstrate substantial within-host diversity and retained pathogenic potential

F. M. Anderson, N. Visser, K. Amses, A. Hodgins-Davis, A. M. Weber, K. M. Metzner, M. J. McFadden, R. E. Mills, M. J. O'Meara, T. Y. James, T. R. OMeara

The paper examines genetic and phenotypic diversity in commensal Candida albicans strains from healthy donors and shows they retain pathogenic potential.

bioRxiv · Sep 9, 2022 · PreprintMicrobiology

An adjuvanted SARS-CoV-2 RBD nanoparticle elicits neutralizing antibodies and fully protective immunity in aged mice

F. Borriello, E. Nanishi, H.-S. Seo, T. R. OMeara, M. E. McGrath, Y. Saito, R. E. Haupt, J. Chen, J. Diray-Arce, K. Song, A. Z. Xu, T. M. Caradonna, J. Feldman, B. M. Hauser, A. G. Schmidt, , O. Levy

This study identifies an adjuvanted SARS-CoV-2 RBD nanoparticle that induces neutralizing antibodies and full protection in aged mice.

bioRxiv · Sep 9, 2021 · PreprintImmunology